TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.74 -0.25 (-33.69%) 0.0 (0.39%) 0.01 (1.92%) -0.19 (-27.57%) -0.25 (-33.69%) 0.42 (94.36%) -0.14 (-16.57%) -0.35 (-41.8%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.2536
Diluted P/E:
-0.2536
RSI(14) 1m:
62.84
VWAP:
0.49
RVol:
0.5545

Events

Period Kind Movement Occurred At
1m Price decrease 1m 0.7 -0.02 (-2.38%) Oct 15 16:19
1m Price decrease 1m 0.7 -0.02 (-2.38%) Oct 15 16:19
1m Price decrease 1m 0.7 -0.02 (-2.38%) Oct 15 16:19
1m Price decrease 1m 0.7 -0.02 (-2.38%) Oct 15 16:19
1m Price decrease 1m 0.7 -0.02 (-2.38%) Oct 15 16:19

Related News